» Articles » PMID: 22000015

An Extensive MicroRNA-mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2011 Oct 18
PMID 22000015
Citations 410
Authors
Affiliations
Soon will be listed here.
Abstract

By analyzing gene expression data in glioblastoma in combination with matched microRNA profiles, we have uncovered a posttranscriptional regulation layer of surprising magnitude, comprising more than 248,000 microRNA (miR)-mediated interactions. These include ∼7,000 genes whose transcripts act as miR "sponges" and 148 genes that act through alternative, nonsponge interactions. Biochemical analyses in cell lines confirmed that this network regulates established drivers of tumor initiation and subtype implementation, including PTEN, PDGFRA, RB1, VEGFA, STAT3, and RUNX1, suggesting that these interactions mediate crosstalk between canonical oncogenic pathways. siRNA silencing of 13 miR-mediated PTEN regulators, whose locus deletions are predictive of PTEN expression variability, was sufficient to downregulate PTEN in a 3'UTR-dependent manner and to increase tumor cell growth rates. Thus, miR-mediated interactions provide a mechanistic, experimentally validated rationale for the loss of PTEN expression in a large number of glioma samples with an intact PTEN locus.

Citing Articles

Modeling ncRNA Synergistic Regulation in Cancer.

Zhang J, Xiong C, Wei X, Yang H, Zhao C Methods Mol Biol. 2024; 2883:377-402.

PMID: 39702718 DOI: 10.1007/978-1-0716-4290-0_17.


Out-of-Equilibrium ceRNA Crosstalk.

Ferro E, Szischik C, Cunial M, Ventura A, De Martino A, Bosia C Methods Mol Biol. 2024; 2883:167-193.

PMID: 39702709 DOI: 10.1007/978-1-0716-4290-0_8.


Informeasure: an R/bioconductor package for quantifying nonlinear dependence between variables in biological networks from an information theory perspective.

Pan C, Chen Y BMC Bioinformatics. 2024; 25(1):382.

PMID: 39695935 PMC: 11658358. DOI: 10.1186/s12859-024-05996-z.


Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy.

To K, Zhang H, Cho W Cancer Drug Resist. 2024; 7:37.

PMID: 39403602 PMC: 11472581. DOI: 10.20517/cdr.2024.66.


Coding, or non-coding, that is the question.

Poliseno L, Lanza M, Pandolfi P Cell Res. 2024; 34(9):609-629.

PMID: 39054345 PMC: 11369213. DOI: 10.1038/s41422-024-00975-8.


References
1.
Kwak H, Kim Y, Chun K, Woo Y, Park S, Jeong J . Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene. 2011; 30(21):2433-42. DOI: 10.1038/onc.2010.620. View

2.
Godlewski J, Nowicki M, Bronisz A, Williams S, Otsuki A, Nuovo G . Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008; 68(22):9125-30. DOI: 10.1158/0008-5472.CAN-08-2629. View

3.
Carro M, Lim W, Alvarez M, Bollo R, Zhao X, Snyder E . The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2009; 463(7279):318-25. PMC: 4011561. DOI: 10.1038/nature08712. View

4.
Zhou Y, Chen L, Barlogie B, Stephens O, Wu X, Williams D . High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. Proc Natl Acad Sci U S A. 2010; 107(17):7904-9. PMC: 2867889. DOI: 10.1073/pnas.0908441107. View

5.
Chatterjee S, Fasler M, Bussing I, Grosshans H . Target-mediated protection of endogenous microRNAs in C. elegans. Dev Cell. 2011; 20(3):388-96. DOI: 10.1016/j.devcel.2011.02.008. View